
About Medtronic
Medtronic (NYSE:MDT) is a global healthcare solutions company focused on developing and providing innovative medical technologies and services. With operations spanning across more than 150 countries, Medtronic aims to alleviate pain, restore health, and extend life for millions of people around the world. The company's projects are diverse and cover a broad range of health conditions, including cardiac and vascular diseases, diabetes, neurological conditions, and more. Medtronic is committed to improving clinical outcomes, expanding access to care, and optimizing cost and efficiency within the healthcare system. At its core, Medtronic's objective is to contribute to human welfare by applying biomedical engineering to the research, design, manufacture, and sale of medical devices and services.
Snapshot
Operations
Produtos e/ou serviços de Medtronic
- Among key products, the MiniMed insulin pump system automates insulin delivery, improving diabetes management.
- The Guardian Connect CGM system offers continuous glucose tracking and alerts for diabetic patients.
- The Resolute Onyx DES is a drug-eluting stent that prevents artery re-narrowing post-angioplasty.
- TyRx is an absorbable antibacterial technology employed in implanted devices to prevent infections.
- The In.Pact Admiral drug-coated balloon assists in peripheral artery disease treatment and prevents restenosis.
- The Micra TPS is a miniaturized pacemaker offering sophisticated monitoring while alleviating traditional pacemaker side effects.
equipe executiva do Medtronic
- Mr. Geoffrey Straub MarthaChairman of the Board & CEO
- Mr. Thierry PietonExecutive VP & CFO
- Mr. Gary CoronaSenior VP of Corporate Finance
- Mr. Brett A. WallExecutive VP & President of Neuroscience Portfolio
- Mr. Mark PloofSenior Vice President of Global Operations and Business Services
- Ms. Denise L. BlomquistVP, Global Controller & Chief Accounting Officer
- Dr. Laura Mauri M.D., M.Sc.Senior VP and Chief Scientific & Medical Officer
- Mr. Ryan WeispfenningVP & Head of Investor Relations
- Ms. Michelle QuinnExecutive VP, General Counsel & Secretary
- Mr. Scott CundySenior VP, Chief Quality, Development, & Innovation Officer